| Authors: |
Rolland F; National Institute of Health and Medical Research (Inserm) U1018, Center for research in epidemiology and population health (CESP), Paris-Saclay University, Villejuif, France; MGEN action sanitaire et sociale - groupe VYV, établissement de santé mentale de Rueil-Malmaison, 2, rue du Lac, 92500 Rueil-Malmaison, France. Electronic address: frolland1@mgen.fr., Frajerman A; Inserm, MOODS Team, CESP, faculté de médecine Paris-Saclay, université Paris-Saclay, Le Kremlin-Bicêtre, France; Service hospitalo-universitaire de psychiatrie de Bicêtre, Mood Center Paris Saclay, hôpitaux universitaires Paris-Saclay, hôpital de Bicêtre, AP-HP, Le Kremlin-Bicêtre, France., Falissard B; National Institute of Health and Medical Research (Inserm) U1018, Center for research in epidemiology and population health (CESP), Paris-Saclay University, Villejuif, France., Benyamina A; National Institute of Health and Medical Research (Inserm) U1018, Center for research in epidemiology and population health (CESP), Paris-Saclay University, Villejuif, France., Diquet B; Laboratoire de pharmacologie-toxicologie, institut de biologie en santé, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex, France., Vinchon F; LaPEA, université Paris Cité, université Gustave-Eiffel, 92100 Boulogne-Billancourt, France., Bertschy G; Department of Psychiatry, Mental Health and Addictology, Strasbourg University Hospital, 67000 Strasbourg, France; Inserm U1114, 67000 Strasbourg, France; Translational Medicine Federation, University of Strasbourg, 67000 Strasbourg, France., Marra D; Médecine de santé au travail, hopices civils de Lyon, Lyon, France. |
